May Edition
AGC Biologics
We work side by side with our customers to improve patients’ lives by bringing new biopharmaceutical products to market.
AGC Biologics Partners with Novelty Nobility on Production of an Antibody Drug Candidate
Novelty Nobility, a clinical-stage biotech company based in South Korea, will work with AGC Biologics’ Copenhagen, Denmark and Chiba, Japan facilities to develop and produce a first-in-class bispecific antibody drug candidate. This multiphase project will begin with cell line development then expand to process development and GMP manufacturing.
AGC Biologics Announces Partnership with Quell Therapeutics to Advance Treg Cell Therapies
AGC Biologics is partnering with Quell Therapeutics, a leader in developing engineered T regulatory (Treg) cell therapies. AGC Biologics is supplying lentiviral vector (LVV) material using our ProntoLVV™ platform from the Milan Cell and Gene Center of Excellence to support Quell's development of multiple Treg cell therapy drug candidates for severe immune disorders, preparing them for clinical trial application/investigational new drug submissions.
New Yokohama Facility Begins Cell Therapy Process Development Services in July
AGC Biologics is excited to announce that our cell therapy process development services in Yokohama, Japan, will begin operations in July! This marks the start of our new CDMO services coming to this site. We invite you to contact our team to schedule a visit and explore our development capabilities for customers in Asia and around the globe.
On-Demand Webinar: Meeting the Needs for Antibody-Drug Conjugate Manufacturing Services
Learn how AGC Biologics is meeting the growing demand for end-to-end ADC manufacturing services through our Proveo™ alliance. Proveo, provides complete ADC services under a single contract and can advance products from DNA to fill & finish in just 15 months!
Webinar: Building End-to-End Cell Therapy Manufacturing Strategies
Access this informative recording to learn from Luca Alberici, AGC Biologics' EVP, Global Cell & Gene Technologies and Milan General Manager, as he discusses the different types of cell therapy manufacturing available for developers. He also delves into the benefits, challenges, and requirements for each, along with fill/finish options, facility design, and how to achieve a closed manufacturing process.
BIO International, June 16-19
We look forward to seeing you at BIO International 2025, June 16-19, in Boston! Request a meeting with our representatives attending the event ahead of time. We will be at booth #3165ready to chat about protein-based biologics or advanced therapies projects.
Each month, we spotlight key content in the dynamic world of biotech. Whether it's the latest insights on cell and gene therapy, breakthroughs in biologics production, or cutting-edge industry trends, you'll find valuable knowledge here. If you're hungry for more, be sure to explore our full content library for in-depth resources and exclusive updates!
Dive into this month's featured case study, white paper and service!
Case Study:
Enhanced Contamination Control with Advanced Microbial Identification
Discover how our implementation of the MALDI-TOF system significantly improves microbial identification, reducing turnaround times by over 50%. This advancement enhances our agility in contamination response, enables cost savings, and supports more effective root cause analysis.
White Paper:
Manufacturing Process Transfer: Understanding Challenges & Keys to Success
Navigate the complexities of technology transfer with confidence. Gain valuable insights into the critical factors, common pitfalls, and key strategies for a successful transfer process in biopharmaceutical manufacturing, helping you mitigate risks, avoid costly delays, and ensure a smooth transition for your product.
Featured Service:
Proveo™
Explore Proveo™, our complete antibody drug conjugate (ADC) solution that covers all phases of development and manufacturing under one contract. Industry-leading expertise in monoclonal antibody production, bioconjugation and linker-payload, and aseptic fill and lyophilization services combine to provide ADCs on an expedited timeline.
We have an incredible team of people at AGC Biologics who work hard every day to help improve patients’ lives. Get to know this month’s featured team member.
Meet Ellen Segefalk, Student Assistant in People & Culture Operations in Copenhagen.
Meet Amy Brown, Supervisor, Master & Finite Scheduling in Seattle.
Neurophysiologist at Clinical NeuroDiagnostics
4moCongrats! Well said and looking forward to hearing more about your journey and projects.